Related Experiment Video
Updated: Feb 3, 2026

Isolation of Cancer Stem Cells From Human Prostate Cancer Samples
Published on: March 14, 2014
Targeting an Autocrine Regulatory Loop in Cancer Stem-like Cells Impairs the Progression and Chemotherapy Resistance
Kai-Jian Wang1, Chao Wang1, Li-He Dai1
1Department of Urology, Changhai Hospital, Second Military Medical University (Naval Medical University), Shanghai, China.
Purpose:
Cancer stem-like cells (CSCs) contribute to bladder cancer chemotherapy resistance and progression, but the associated mechanisms have not been elucidated. This study determined whether blocking an autocrine signaling loop in CSCs improves the therapeutic effects of cis-platinum on bladder cancer.
Experimental Design:
The expression of the epithelial marker OV6 and other markers in human bladder cancer specimens was examined by IHC. The CSC properties of magnetic-activated cell sorting (MACS)-isolated OV6+ and OV6- bladder cancer cells were examined. Molecular mechanisms were assessed through RNA-Seq, cytokine antibody arrays, co-immunoprecipitation (co-IP), chromatin immunoprecipitation (ChIP) and other assays. An orthotopic bladder cancer mouse model was established to evaluate the in vivo effects of a YAP inhibitor (verteporfin) and a PDGFR inhibitor (CP-673451) on the cis-platinum resistance of OV6+ CSCs in bladder cancer.
Results:
Upregulated OV6 expression positively associated with disease progression and poor prognosis for bladder cancer patients. Compared with OV6- cells, OV6+ bladder cancer cells exhibited strong CSC characteristics, including self-renewal, tumor initiation in NOD/SCID mice, and chemotherapy resistance. YAP, which maintains the stemness of OV6+ CSCs, triggered PDGFB transcription by recruiting TEAD1. Autocrine PDGF-BB signaling through its receptor PDGFR stabilized YAP and facilitated YAP nuclear translocation. Furthermore, blocking the YAP/TEAD1/PDGF-BB/PDGFR loop with verteporfin or CP-673451 inhibited the cis-platinum resistance of OV6+ bladder cancer CSCs in an orthotopic bladder cancer model.
Conclusions:
OV6 could be a helpful indicator of disease progression and prognosis for patients with bladder cancer, and targeting the autocrine YAP/TEAD1/PDGF-BB/PDGFR loop might serve as a remedy for cis-platinum resistance in patients with advanced bladder cancer.
Insights
Blocking a specific signaling loop in cancer stem cells can overcome chemotherapy resistance in bladder cancer. This finding offers a potential new treatment strategy for advanced bladder cancer patients.
Area of Science:
- Oncology
- Cancer Stem Cell Biology
- Chemotherapy Resistance Mechanisms
Background:
- Cancer stem-like cells (CSCs) are implicated in bladder cancer progression and resistance to chemotherapy.
- The precise molecular mechanisms driving CSC-mediated resistance remain incompletely understood.
- This study investigates a potential autocrine signaling loop within CSCs contributing to therapeutic failure.
Purpose of the Study:
- To determine if inhibiting an autocrine signaling loop in bladder cancer stem cells can enhance the efficacy of cisplatin chemotherapy.
- To elucidate the role of OV6 expression and associated signaling pathways in bladder cancer stem cell properties and chemoresistance.
Main Methods:
- Immunohistochemistry (IHC) was used to assess OV6 expression in human bladder cancer tissues.
- Magnetic-activated cell sorting (MACS) isolated OV6+ and OV6- bladder cancer cells for functional assays.
- Molecular analyses included RNA-Seq, cytokine arrays, co-IP, ChIP, and an orthotopic mouse model to test YAP and PDGFR inhibitors.
Main Results:
- High OV6 expression correlated with advanced bladder cancer, poor prognosis, and enhanced CSC characteristics (self-renewal, tumor initiation, chemoresistance).
- The YAP/TEAD1 pathway was identified as crucial for maintaining OV6+ CSC stemness and triggering PDGFB transcription.
- Inhibition of the YAP/TEAD1/PDGF-BB/PDGFR signaling loop using verteporfin or CP-673451 significantly reduced cisplatin resistance in OV6+ bladder cancer CSCs in vivo.
Conclusions:
- OV6 serves as a potential biomarker for bladder cancer progression and patient prognosis.
- Targeting the autocrine YAP/TEAD1/PDGF-BB/PDGFR signaling loop represents a promising therapeutic strategy to overcome cisplatin resistance.
- This approach may offer a novel treatment option for patients with advanced bladder cancer exhibiting chemoresistance.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Treatment Resistant Cancers
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Distinctive Features of Adult Stem Cells vs Cancer Stem Cells
Adult stem cells
Adult stem cells are tissue-specific; hence, they divide to develop the tissue from which they originate. One type of adult stem cell is the epithelial stem cell, which gives rise to the keratinocytes in the multiple layers of epithelial cells in the epidermis of the skin. Adult bone marrow has three distinct types of stem cells:...
Cancer

